What are non-benzodiazepine medications for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025 • View editorial policy

From the Guidelines

Non-benzodiazepine medications for anxiety include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), buspirone, hydroxyzine, and beta-blockers, which offer alternatives to benzodiazepines with a lower risk of dependence and tolerance. These medications work by regulating neurotransmitters like serotonin, norepinephrine, and GABA that influence mood and anxiety. Some key options include:

  • SSRIs like sertraline (50-200 mg daily), escitalopram (10-20 mg daily), and fluoxetine (20-80 mg daily) which are typically first-line treatments, taking 2-4 weeks to show full benefits but requiring consistent daily use 1.
  • SNRIs such as venlafaxine (75-225 mg daily) and duloxetine (30-120 mg daily) which are also effective, particularly for anxiety with comorbid pain 2.
  • Buspirone (15-60 mg daily, divided into 2-3 doses) which works on serotonin receptors and is non-sedating and non-addictive 3.
  • Hydroxyzine (25-100 mg as needed) which can help with acute anxiety symptoms.
  • Beta-blockers like propranolol (10-40 mg as needed) which effectively manage physical symptoms of anxiety such as trembling and rapid heartbeat. It's essential to consider the potential side effects and interactions of these medications, as well as individual patient factors, when selecting a treatment option 4, 5, 6.

From the FDA Drug Label

Buspirone hydrochloride tablets, USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs. One non-benzodiazepine medication for anxiety is buspirone 7.

  • Buspirone is an antianxiety agent that is not related to benzodiazepines.

From the Research

Non-Benzodiazepine Medications for Anxiety

Non-benzodiazepine medications for anxiety include:

  • Selective serotonin reuptake inhibitors (SSRIs) such as sertraline, paroxetine, and fluoxetine 8, 9, 10
  • Serotonin-noradrenaline reuptake inhibitors (SNRIs) such as venlafaxine, milnacipran, and duloxetine 8, 11
  • Atypical anxiolytics such as pregabalin 12
  • Non-SSRI antidepressants such as nefazodone, trazodone, and mirtazapine 8
  • Buspirone, a non-benzodiazepine anxiolytic 8, 11

Characteristics of Non-Benzodiazepine Medications

These medications have various characteristics, including:

  • Rapid onset of action, with some medications showing efficacy within the first week of treatment 12
  • Efficacy in treating symptoms of generalized anxiety disorder, post-traumatic stress disorder, and other anxiety disorders 8, 12, 9, 10, 11
  • Favorable side effect profiles and safety records, making them suitable for long-term treatment 8, 9, 11
  • Potential advantages over benzodiazepines, including reduced risk of dependence and withdrawal 11

Comparison of Non-Benzodiazepine Medications

Studies have compared the efficacy and tolerability of different non-benzodiazepine medications, including:

  • Paroxetine and sertraline, which showed similar efficacy and tolerability in treating generalized anxiety disorder 10
  • Pregabalin and sertraline, which showed similar efficacy but with a more rapid onset of action for pregabalin 12

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.

International journal of psychiatry in clinical practice, 2006

Research

Pregabalin versus sertraline in generalized anxiety disorder. An open label study.

European review for medical and pharmacological sciences, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.